ASH 2020 | Visit our poster on myeloma patient information needs and preferences at ASH 2020!Conferences, MPE, MyelomaDecember 5, 2020
FDA Refusal to File letter for Idecabtagene Vicleucel (ide-cel, bb2121) for the treatment of myeloma patientsAccess, MyelomaMay 14, 2020
MPE webinar on the impact of myeloma and AL amyloidosis in carers. What are the issues and challenges?AL amyloidosis, MPE, MyelomaMay 8, 2020
MPE webinar on personalised medicines in myeloma and AL amyloidosisAL amyloidosis, MPE, MyelomaApril 28, 2020
MPE webinar on Minimal Residual Disease (MRD) in myeloma and related diseasesMPE, MyelomaApril 13, 2020
Watch the webinar on ASH 2019 highlights held yesterday by Myeloma Patients Europe (MPE)AL amyloidosis, Conferences, MPE, Myeloma, VideosJanuary 15, 2020
MPE webinar on ASH 2019 myeloma and AL amyloidosis highlightsAL amyloidosis, Conferences, MPE, MyelomaDecember 20, 2019
